Condition: RASopathies · Noonan Syndrome · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
RASopathies, including Noonan syndrome, involve dysmorphisms, metabolic alterations, and an unfavorable lipid profile. This study investigates lipid and glucose metabolism to improve patient care.
This description comes directly from the study's public registry record.
Federica Tamburrino · 00390512143723 · federica.tamburrino@aosp.bo.it
Always discuss trial participation with your own doctor first.
| Azienda Ospedaliero-Universitaria di Alessandria | Alessandria, Italy | Not Yet Recruiting |
| AOU Policlinico di Bari | Bari, Italy | Not Yet Recruiting |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | Bologna, Italy | Recruiting |
| AOU Meyer IRCCS | Florence, Italy | Recruiting |
| IRCCS Istituto Giannina Gaslini | Genova, Italy | Recruiting |
| AOU Policlinico G. Martino | Messina, Italy | Not Yet Recruiting |
| Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico | Milan, Italy | Not Yet Recruiting |
| IRCCS Ospedale San Raffaele | Milan, Italy | Not Yet Recruiting |
| Azienda Ospedaliera Policlinico di Modena | Modena, Italy | Not Yet Recruiting |
| Fondazione IRCCS San Gerardo dei Tintori | Monza, Italy | Not Yet Recruiting |
| AOU Vanvitelli | Naples, Italy | Not Yet Recruiting |
| Azienda Ospedale-Università di Padova | Padova, Italy | Not Yet Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07464821